Search Results - "Lauer, Kate V."

The Antiviral and Cancer Genomic DNA Deaminase APOBEC3H Is Regulated by an RNA-Mediated Dimerization Mechanism by Shaban, Nadine M., Shi, Ke, Lauer, Kate V., Carpenter, Michael A., Richards, Christopher M., Salamango, Daniel, Wang, Jiayi, Lopresti, Michael W., Banerjee, Surajit, Levin-Klein, Rena, Brown, William L., Aihara, Hideki, Harris, Reuben S.

“…Human APOBEC3H and homologous single-stranded DNA cytosine deaminases are unique to mammals. These DNA-editing enzymes function in innate immunity by…”
Get full text

Identifying Intraoperative Behaviors Associated With Surgical Resident Teachability by Lauer, Kate V., Jung, Sarah A., Elfenbein, Dawn M.

“…•Teachability is not associated with intraoperative active learning behaviors•Intraoperative questions may increase magnitude of operative…”
Get full text

Exploring Social Support Dynamics After Bariatric Surgery: Insights From Patients and Providers by Jawara, Dawda, Alagoz, Esra, Lauer, Kate V., Voils, Corrine I., Funk, Luke M.

“…Weight loss after bariatric surgery is impacted by several factors, and social support is one of them. Our objective was to characterize patient and provider…”
Get full text

U.S. weight trends: a longitudinal analysis of an NIH-partnered dataset by Jawara, Dawda, Krebsbach, Craig M, Venkatesh, Manasa, Murtha, Jacqueline A, Hanlon, Bret M, Lauer, Kate V, Stalter, Lily N, Funk, Luke M

“…Obesity is a major public health challenge in the U.S. Existing datasets utilized for calculating obesity prevalence, such as the National Health and Nutrition…”
Get full text

The Role of RNA in HIV-1 Vif-Mediated Degradation of APOBEC3H by Wang, Jiayi, Becker, Jordan T., Shi, Ke, Lauer, Kate V., Salamango, Daniel J., Aihara, Hideki, Shaban, Nadine M., Harris, Reuben S.

“…As many as five members of the APOBEC3 family of DNA cytosine deaminases are capable of inhibiting HIV-1 replication by deaminating viral cDNA cytosines and…”
Get full text

Expectations for overall survival in mRCC patients who were selected for upfront cytoreductive nephrectomy in the targeted therapy era by Abel, E. Jason, Karam, Jose A., Spiess, Philippe E., Raman, Jay D., Sexton, Wade J., Zemp, Logan, Bilotta, Alyssa, Patil, Dattatraya, Allen, Glenn O., Lauer, Kate V., Shapiro, Daniel D., Matin, Surena F., Wood, Christopher G.

“…Abstract only 646 Background: Surgical selection is critical to obtain the best outcomes for mRCC patients treated with cytoreductive nephrectomy (CN). Prior…”
Get full text

Preoperative metastatic disease burden to predict overall survival following cytoreductive nephrectomy independent of IMDC risk category by Shapiro, Daniel D., Karam, Jose A., Spiess, Philippe E., Raman, Jay D., Westerman, Mary E., Sexton, Wade J., Zemp, Logan, Bilotta, Alyssa, Allen, Glenn O., Lauer, Kate V., Matin, Surena F., Wood, Christopher G., Abel, E. Jason

“…Abstract only 652 Background: Studies suggest that overall survival (OS) following cytoreductive nephrectomy (CN) is associated with preoperative tumor…”
Get full text